

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein heterotrimerization (GO:0070208) | 5.97600139 |
| 2 | vascular endothelial growth factor signaling pathway (GO:0038084) | 5.04648348 |
| 3 | regulation of complement activation (GO:0030449) | 4.85932756 |
| 4 | collagen fibril organization (GO:0030199) | 4.84846970 |
| 5 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.81483102 |
| 6 | regulation of protein activation cascade (GO:2000257) | 4.78041064 |
| 7 | regulation of cholesterol homeostasis (GO:2000188) | 4.61262620 |
| 8 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 4.54070076 |
| 9 | plasma lipoprotein particle assembly (GO:0034377) | 4.51409930 |
| 10 | negative regulation of protein activation cascade (GO:2000258) | 4.49735264 |
| 11 | glucocorticoid biosynthetic process (GO:0006704) | 4.47070810 |
| 12 | basement membrane organization (GO:0071711) | 4.41932532 |
| 13 | intestinal cholesterol absorption (GO:0030299) | 4.38574628 |
| 14 | protein-lipid complex assembly (GO:0065005) | 4.32734498 |
| 15 | negative regulation of fibrinolysis (GO:0051918) | 4.32050594 |
| 16 | regulation of apoptotic cell clearance (GO:2000425) | 4.30959531 |
| 17 | blood vessel maturation (GO:0001955) | 4.28447871 |
| 18 | lymph vessel development (GO:0001945) | 4.25198268 |
| 19 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 4.17939900 |
| 20 | glomerular basement membrane development (GO:0032836) | 4.13965957 |
| 21 | plasma lipoprotein particle clearance (GO:0034381) | 4.02100104 |
| 22 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.02095756 |
| 23 | protein carboxylation (GO:0018214) | 4.02095756 |
| 24 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.93672249 |
| 25 | low-density lipoprotein particle remodeling (GO:0034374) | 3.93392193 |
| 26 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.89500240 |
| 27 | lymphangiogenesis (GO:0001946) | 3.88371736 |
| 28 | progesterone metabolic process (GO:0042448) | 3.88042649 |
| 29 | cholesterol efflux (GO:0033344) | 3.85746924 |
| 30 | axon extension involved in axon guidance (GO:0048846) | 3.82425478 |
| 31 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.82425478 |
| 32 | glucocorticoid metabolic process (GO:0008211) | 3.80993019 |
| 33 | C21-steroid hormone metabolic process (GO:0008207) | 3.75984822 |
| 34 | collagen metabolic process (GO:0032963) | 3.72112087 |
| 35 | protein-lipid complex remodeling (GO:0034368) | 3.64611201 |
| 36 | macromolecular complex remodeling (GO:0034367) | 3.64611201 |
| 37 | plasma lipoprotein particle remodeling (GO:0034369) | 3.64611201 |
| 38 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 3.62273952 |
| 39 | chondrocyte proliferation (GO:0035988) | 3.60374443 |
| 40 | plasma lipoprotein particle organization (GO:0071827) | 3.59799084 |
| 41 | multicellular organismal macromolecule metabolic process (GO:0044259) | 3.58632029 |
| 42 | collagen catabolic process (GO:0030574) | 3.58154954 |
| 43 | protein-lipid complex subunit organization (GO:0071825) | 3.55164657 |
| 44 | regulation of fibrinolysis (GO:0051917) | 3.52570391 |
| 45 | regulation of cholesterol esterification (GO:0010872) | 3.49492030 |
| 46 | positive regulation of extracellular matrix organization (GO:1903055) | 3.49191750 |
| 47 | androgen biosynthetic process (GO:0006702) | 3.45745829 |
| 48 | positive regulation of hormone biosynthetic process (GO:0046886) | 3.45034002 |
| 49 | multicellular organismal metabolic process (GO:0044236) | 3.42628818 |
| 50 | extracellular fibril organization (GO:0043206) | 3.38568043 |
| 51 | * definitive hemopoiesis (GO:0060216) | 3.37395962 |
| 52 | complement activation, alternative pathway (GO:0006957) | 3.34933309 |
| 53 | skin morphogenesis (GO:0043589) | 3.34772233 |
| 54 | endodermal cell differentiation (GO:0035987) | 3.33875542 |
| 55 | multicellular organismal catabolic process (GO:0044243) | 3.33486325 |
| 56 | fibroblast migration (GO:0010761) | 3.33176173 |
| 57 | ovulation from ovarian follicle (GO:0001542) | 3.32112256 |
| 58 | glomerular filtration (GO:0003094) | 3.31366694 |
| 59 | blood coagulation, intrinsic pathway (GO:0007597) | 3.30781868 |
| 60 | cardiac myofibril assembly (GO:0055003) | 3.29994828 |
| 61 | high-density lipoprotein particle remodeling (GO:0034375) | 3.23329360 |
| 62 | estrogen biosynthetic process (GO:0006703) | 3.22464702 |
| 63 | bone trabecula formation (GO:0060346) | 3.22084401 |
| 64 | negative regulation of humoral immune response (GO:0002921) | 3.21572777 |
| 65 | fibril organization (GO:0097435) | 3.20319427 |
| 66 | * response to follicle-stimulating hormone (GO:0032354) | 3.20109429 |
| 67 | hemidesmosome assembly (GO:0031581) | 3.18492874 |
| 68 | intestinal absorption (GO:0050892) | 3.17496925 |
| 69 | apoptotic cell clearance (GO:0043277) | 3.15832065 |
| 70 | endocrine hormone secretion (GO:0060986) | 3.15563438 |
| 71 | low-density lipoprotein particle clearance (GO:0034383) | 3.13744618 |
| 72 | endothelial cell proliferation (GO:0001935) | 3.13565002 |
| 73 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.12965608 |
| 74 | renal filtration (GO:0097205) | 3.12776961 |
| 75 | valine metabolic process (GO:0006573) | 3.11006974 |
| 76 | cell migration involved in heart development (GO:0060973) | 3.10542219 |
| 77 | lung epithelium development (GO:0060428) | 3.09391150 |
| 78 | phagocytosis, recognition (GO:0006910) | 3.09036774 |
| 79 | positive regulation of steroid metabolic process (GO:0045940) | 3.08662236 |
| 80 | extracellular matrix disassembly (GO:0022617) | 3.08605170 |
| 81 | reverse cholesterol transport (GO:0043691) | 3.07497020 |
| 82 | regulation of plasminogen activation (GO:0010755) | 3.07110758 |
| 83 | positive regulation of hormone metabolic process (GO:0032352) | 3.06035165 |
| 84 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 3.05760840 |
| 85 | cell migration involved in sprouting angiogenesis (GO:0002042) | 3.05512421 |
| 86 | diacylglycerol metabolic process (GO:0046339) | 3.05287899 |
| 87 | substrate adhesion-dependent cell spreading (GO:0034446) | 3.00220913 |
| 88 | C21-steroid hormone biosynthetic process (GO:0006700) | 3.00099177 |
| 89 | endothelial cell morphogenesis (GO:0001886) | 2.99766853 |
| 90 | venous blood vessel morphogenesis (GO:0048845) | 2.99133408 |
| 91 | epithelial cell-cell adhesion (GO:0090136) | 2.99097302 |
| 92 | positive regulation of fatty acid oxidation (GO:0046321) | 2.98864304 |
| 93 | regulation of extracellular matrix disassembly (GO:0010715) | 2.98783943 |
| 94 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 2.98776304 |
| 95 | regulation of steroid hormone biosynthetic process (GO:0090030) | 2.98737229 |
| 96 | lipoprotein metabolic process (GO:0042157) | 2.97890146 |
| 97 | regulation of sequestering of triglyceride (GO:0010889) | 2.97517461 |
| 98 | acylglycerol catabolic process (GO:0046464) | 2.94935533 |
| 99 | neutral lipid catabolic process (GO:0046461) | 2.94935533 |
| 100 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.94627210 |
| 101 | regulation of cholesterol storage (GO:0010885) | 2.93703824 |
| 102 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.93591012 |
| 103 | cholesterol transport (GO:0030301) | 2.93027495 |
| 104 | sterol transport (GO:0015918) | 2.93027495 |
| 105 | hippo signaling (GO:0035329) | 2.91199299 |
| 106 | cell adhesion mediated by integrin (GO:0033627) | 2.90563757 |
| 107 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.90266457 |
| 108 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.87468160 |
| 109 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.87150639 |
| 110 | blood vessel endothelial cell migration (GO:0043534) | 2.86389654 |
| 111 | negative regulation of norepinephrine secretion (GO:0010700) | 2.85604088 |
| 112 | growth hormone receptor signaling pathway (GO:0060396) | 2.85431298 |
| 113 | smooth muscle tissue development (GO:0048745) | 2.83158753 |
| 114 | cell-substrate junction assembly (GO:0007044) | 2.82937519 |
| 115 | cell proliferation involved in metanephros development (GO:0072203) | 2.82592222 |
| 116 | extracellular matrix assembly (GO:0085029) | 2.82413147 |
| 117 | triglyceride catabolic process (GO:0019433) | 2.82381111 |
| 118 | positive regulation of epithelial to mesenchymal transition (GO:0010718) | 2.80859287 |
| 119 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.79931433 |
| 120 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.79923815 |
| 121 | sprouting angiogenesis (GO:0002040) | 2.79767586 |
| 122 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.78729267 |
| 123 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.78484243 |
| 124 | brown fat cell differentiation (GO:0050873) | 2.77365498 |
| 125 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.76794493 |
| 126 | vitamin transmembrane transport (GO:0035461) | 2.76648942 |
| 127 | regulation of humoral immune response (GO:0002920) | 2.76151928 |
| 128 | glomerular visceral epithelial cell development (GO:0072015) | 2.73562128 |
| 129 | cellular response to growth hormone stimulus (GO:0071378) | 2.72962563 |
| 130 | positive regulation of p38MAPK cascade (GO:1900745) | 2.71738361 |
| 131 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.71013461 |
| 132 | positive regulation of lipid storage (GO:0010884) | 2.70653435 |
| 133 | fatty acid homeostasis (GO:0055089) | 2.70116707 |
| 134 | cellular response to antibiotic (GO:0071236) | 2.70027837 |
| 135 | * trabecula formation (GO:0060343) | 2.69949544 |
| 136 | cellular response to epinephrine stimulus (GO:0071872) | 2.69477307 |
| 137 | keratan sulfate catabolic process (GO:0042340) | 2.69446036 |
| 138 | negative regulation of complement activation (GO:0045916) | 2.67835748 |
| 139 | negative regulation of fatty acid transport (GO:2000192) | 2.66827655 |
| 140 | myofibril assembly (GO:0030239) | 2.65445894 |
| 141 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.65432959 |
| 142 | patterning of blood vessels (GO:0001569) | 2.63827751 |
| 143 | plasma membrane repair (GO:0001778) | 2.63479204 |
| 144 | regulation of tight junction assembly (GO:2000810) | 2.62131989 |
| 145 | cell proliferation involved in kidney development (GO:0072111) | 2.61992910 |
| 146 | regulation of bile acid biosynthetic process (GO:0070857) | 2.61762852 |
| 147 | endocardial cushion development (GO:0003197) | 2.61728530 |
| 148 | positive regulation of steroid biosynthetic process (GO:0010893) | 2.61543186 |
| 149 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.61195834 |
| 150 | regulation of endothelial cell differentiation (GO:0045601) | 2.58576001 |
| 151 | regulation of extracellular matrix organization (GO:1903053) | 2.58069703 |
| 152 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.57465795 |
| 153 | COPII vesicle coating (GO:0048208) | 2.57460542 |
| 154 | polyol transport (GO:0015791) | 2.55428423 |
| 155 | mRNA transcription (GO:0009299) | 2.53615243 |
| 156 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.53014143 |
| 157 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.51950977 |
| 158 | muscle filament sliding (GO:0030049) | 2.51250396 |
| 159 | actin-myosin filament sliding (GO:0033275) | 2.51250396 |
| 160 | extracellular matrix organization (GO:0030198) | 2.50610828 |
| 161 | negative regulation of protein autophosphorylation (GO:0031953) | 2.50538451 |
| 162 | protein localization to cell surface (GO:0034394) | 2.50296129 |
| 163 | metanephric mesenchyme development (GO:0072075) | 2.50154782 |
| 164 | extracellular structure organization (GO:0043062) | 2.49436608 |
| 165 | embryonic process involved in female pregnancy (GO:0060136) | 2.48724799 |
| 166 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.47934425 |
| 167 | mesodermal cell differentiation (GO:0048333) | 2.47884029 |
| 168 | endothelial cell chemotaxis (GO:0035767) | 2.47816394 |
| 169 | negative regulation of stress fiber assembly (GO:0051497) | 2.47675207 |
| 170 | pinocytosis (GO:0006907) | 2.47327790 |
| 171 | kidney mesenchyme development (GO:0072074) | 2.46884101 |
| 172 | atrioventricular valve morphogenesis (GO:0003181) | 2.46882102 |
| 173 | acute-phase response (GO:0006953) | 2.46623132 |
| 174 | protein activation cascade (GO:0072376) | 2.46139073 |
| 175 | substrate-dependent cell migration (GO:0006929) | 2.45712832 |
| 176 | negative regulation of lipase activity (GO:0060192) | 2.45190925 |
| 177 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 2.44842894 |
| 178 | actin-mediated cell contraction (GO:0070252) | 2.44352636 |
| 179 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 2.44255684 |
| 180 | positive regulation of glycolytic process (GO:0045821) | 2.44007909 |
| 181 | response to epinephrine (GO:0071871) | 2.43635322 |
| 182 | white fat cell differentiation (GO:0050872) | 2.43202378 |
| 183 | cell-matrix adhesion (GO:0007160) | 2.43018881 |
| 184 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.41478581 |
| 185 | cholesterol homeostasis (GO:0042632) | 2.40058932 |
| 186 | triglyceride homeostasis (GO:0070328) | 2.38228426 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.81738728 |
| 2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 4.74137407 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.17713848 |
| 4 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.90465572 |
| 5 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.63171703 |
| 6 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.96006647 |
| 7 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.95794101 |
| 8 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.89112508 |
| 9 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.84070975 |
| 10 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 2.80314186 |
| 11 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.72375494 |
| 12 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.69329965 |
| 13 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 2.63922009 |
| 14 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.61317779 |
| 15 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.61163265 |
| 16 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.51993210 |
| 17 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.51038342 |
| 18 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.50111584 |
| 19 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.40158263 |
| 20 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 2.36938256 |
| 21 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.33003976 |
| 22 | * CJUN_26792858_Chip-Seq_BT549_Human | 2.31940537 |
| 23 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.29516645 |
| 24 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.29500996 |
| 25 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.28035358 |
| 26 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.16101207 |
| 27 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.14984900 |
| 28 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.11681856 |
| 29 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 2.04083354 |
| 30 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 2.00150665 |
| 31 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.93599042 |
| 32 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.93419373 |
| 33 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.91078252 |
| 34 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.85159716 |
| 35 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.85025471 |
| 36 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.83313443 |
| 37 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.82575740 |
| 38 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.82575740 |
| 39 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.71888717 |
| 40 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.71376606 |
| 41 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.69127707 |
| 42 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.67400965 |
| 43 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.58600889 |
| 44 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.56705507 |
| 45 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.56705507 |
| 46 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.56351408 |
| 47 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.56175307 |
| 48 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.55427277 |
| 49 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.54781147 |
| 50 | GATA1_22025678_ChIP-Seq_K562_Human | 1.54499765 |
| 51 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.51368111 |
| 52 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.43874454 |
| 53 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.40666389 |
| 54 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.39812313 |
| 55 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.39344038 |
| 56 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.38641938 |
| 57 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.38173481 |
| 58 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.38173481 |
| 59 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.37431449 |
| 60 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.32619904 |
| 61 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.30227208 |
| 62 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.29833488 |
| 63 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.27321846 |
| 64 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.27267256 |
| 65 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.27089996 |
| 66 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.26771213 |
| 67 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.25940580 |
| 68 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.25572346 |
| 69 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.21663764 |
| 70 | * ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.21638464 |
| 71 | * TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.20388799 |
| 72 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.19748931 |
| 73 | TP53_16413492_ChIP-PET_HCT116_Human | 1.18302268 |
| 74 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.18206255 |
| 75 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.13372080 |
| 76 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.11497668 |
| 77 | * FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.10906931 |
| 78 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.10468636 |
| 79 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.10324961 |
| 80 | RXR_22108803_ChIP-Seq_LS180_Human | 1.09854475 |
| 81 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.08627702 |
| 82 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.08485946 |
| 83 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.08016586 |
| 84 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.06101631 |
| 85 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.05808121 |
| 86 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.04208615 |
| 87 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.03412110 |
| 88 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.03022147 |
| 89 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.02934281 |
| 90 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.02919529 |
| 91 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.01663102 |
| 92 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.00803899 |
| 93 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.99303078 |
| 94 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.97943037 |
| 95 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.97271627 |
| 96 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.97046338 |
| 97 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.95458420 |
| 98 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.95392924 |
| 99 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.94829278 |
| 100 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.94318771 |
| 101 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.94214423 |
| 102 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.94172018 |
| 103 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.93555750 |
| 104 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.92549578 |
| 105 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.92464509 |
| 106 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.92311054 |
| 107 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.91596975 |
| 108 | GATA1_19941826_ChIP-Seq_K562_Human | 0.89429029 |
| 109 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.89251142 |
| 110 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.87669377 |
| 111 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.87029218 |
| 112 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.85600742 |
| 113 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.84959813 |
| 114 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84767093 |
| 115 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.84682533 |
| 116 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 0.84533104 |
| 117 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.84286066 |
| 118 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.84157970 |
| 119 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.83882276 |
| 120 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.83299424 |
| 121 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.82825787 |
| 122 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.82777367 |
| 123 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.82721209 |
| 124 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.82451897 |
| 125 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.82315423 |
| 126 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.82250684 |
| 127 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.82250684 |
| 128 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.81749740 |
| 129 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.79299743 |
| 130 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.75630664 |
| 131 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.75570676 |
| 132 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.75508956 |
| 133 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.75115154 |
| 134 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.74956588 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 7.07635381 |
| 2 | MP0005275_abnormal_skin_tensile | 4.67833946 |
| 3 | MP0005503_abnormal_tendon_morphology | 4.05802748 |
| 4 | MP0004272_abnormal_basement_membrane | 3.98395501 |
| 5 | MP0003705_abnormal_hypodermis_morpholog | 3.59913938 |
| 6 | MP0006054_spinal_hemorrhage | 3.36782715 |
| 7 | MP0003279_aneurysm | 3.31338087 |
| 8 | MP0010368_abnormal_lymphatic_system | 3.09711887 |
| 9 | MP0001879_abnormal_lymphatic_vessel | 2.68696525 |
| 10 | MP0001958_emphysema | 2.53435147 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.47001967 |
| 12 | MP0003878_abnormal_ear_physiology | 2.30453155 |
| 13 | MP0005377_hearing/vestibular/ear_phenot | 2.30453155 |
| 14 | MP0005670_abnormal_white_adipose | 2.26960192 |
| 15 | MP0003195_calcinosis | 2.01046704 |
| 16 | MP0005365_abnormal_bile_salt | 1.94146187 |
| 17 | MP0004084_abnormal_cardiac_muscle | 1.93163424 |
| 18 | MP0003828_pulmonary_edema | 1.86693669 |
| 19 | MP0000639_abnormal_adrenal_gland | 1.83731682 |
| 20 | MP0005623_abnormal_meninges_morphology | 1.83040122 |
| 21 | MP0002060_abnormal_skin_morphology | 1.81171981 |
| 22 | MP0000751_myopathy | 1.76538017 |
| 23 | MP0000013_abnormal_adipose_tissue | 1.76529381 |
| 24 | MP0003566_abnormal_cell_adhesion | 1.75692539 |
| 25 | MP0000767_abnormal_smooth_muscle | 1.70521928 |
| 26 | MP0003045_fibrosis | 1.69751310 |
| 27 | MP0003950_abnormal_plasma_membrane | 1.66256696 |
| 28 | MP0006138_congestive_heart_failure | 1.65126986 |
| 29 | MP0002108_abnormal_muscle_morphology | 1.62994376 |
| 30 | MP0005508_abnormal_skeleton_morphology | 1.62344790 |
| 31 | MP0003724_increased_susceptibility_to | 1.59539761 |
| 32 | MP0009384_cardiac_valve_regurgitation | 1.59408872 |
| 33 | MP0005023_abnormal_wound_healing | 1.54230831 |
| 34 | MP0005360_urolithiasis | 1.48663262 |
| 35 | MP0002971_abnormal_brown_adipose | 1.47061525 |
| 36 | MP0002909_abnormal_adrenal_gland | 1.43860653 |
| 37 | MP0004130_abnormal_muscle_cell | 1.41534415 |
| 38 | MP0005666_abnormal_adipose_tissue | 1.38133187 |
| 39 | MP0000749_muscle_degeneration | 1.34391172 |
| 40 | MP0002837_dystrophic_cardiac_calcinosis | 1.30979883 |
| 41 | MP0000003_abnormal_adipose_tissue | 1.30156206 |
| 42 | MP0001666_abnormal_nutrient_absorption | 1.29697163 |
| 43 | MP0000750_abnormal_muscle_regeneration | 1.28073840 |
| 44 | MP0003868_abnormal_feces_composition | 1.27053150 |
| 45 | MP0005375_adipose_tissue_phenotype | 1.26299941 |
| 46 | MP0008775_abnormal_heart_ventricle | 1.25772401 |
| 47 | MP0005330_cardiomyopathy | 1.24774150 |
| 48 | MP0004036_abnormal_muscle_relaxation | 1.24343176 |
| 49 | MP0002295_abnormal_pulmonary_circulatio | 1.23268603 |
| 50 | MP0005408_hypopigmentation | 1.23047209 |
| 51 | MP0000343_altered_response_to | 1.19475723 |
| 52 | * MP0005385_cardiovascular_system_phenoty | 1.18717684 |
| 53 | * MP0001544_abnormal_cardiovascular_syste | 1.18717684 |
| 54 | MP0009840_abnormal_foam_cell | 1.17610350 |
| 55 | * MP0010630_abnormal_cardiac_muscle | 1.17122253 |
| 56 | MP0004185_abnormal_adipocyte_glucose | 1.16246378 |
| 57 | MP0002132_abnormal_respiratory_system | 1.14913829 |
| 58 | MP0002877_abnormal_melanocyte_morpholog | 1.14581123 |
| 59 | MP0002128_abnormal_blood_circulation | 1.14173533 |
| 60 | MP0003385_abnormal_body_wall | 1.13775509 |
| 61 | * MP0004087_abnormal_muscle_fiber | 1.12273180 |
| 62 | MP0002118_abnormal_lipid_homeostasis | 1.11857438 |
| 63 | MP0003091_abnormal_cell_migration | 1.10989909 |
| 64 | MP0000733_abnormal_muscle_development | 1.10789490 |
| 65 | MP0003300_gastrointestinal_ulcer | 1.09178554 |
| 66 | MP0004147_increased_porphyrin_level | 1.08325149 |
| 67 | MP0004215_abnormal_myocardial_fiber | 1.06043694 |
| 68 | MP0010352_gastrointestinal_tract_polyps | 1.05390742 |
| 69 | MP0002876_abnormal_thyroid_physiology | 1.03516201 |
| 70 | MP0008875_abnormal_xenobiotic_pharmacok | 1.03463730 |
| 71 | MP0002139_abnormal_hepatobiliary_system | 1.03071392 |
| 72 | MP0005620_abnormal_muscle_contractility | 0.98166621 |
| 73 | MP0002168_other_aberrant_phenotype | 0.97504715 |
| 74 | MP0003191_abnormal_cellular_cholesterol | 0.96736312 |
| 75 | MP0005058_abnormal_lysosome_morphology | 0.96566122 |
| 76 | MP0002972_abnormal_cardiac_muscle | 0.96427886 |
| 77 | MP0009780_abnormal_chondrocyte_physiolo | 0.96395521 |
| 78 | MP0002166_altered_tumor_susceptibility | 0.96173883 |
| 79 | * MP0001614_abnormal_blood_vessel | 0.95825679 |
| 80 | MP0002896_abnormal_bone_mineralization | 0.95262693 |
| 81 | MP0009250_abnormal_appendicular_skeleto | 0.94435158 |
| 82 | MP0005076_abnormal_cell_differentiation | 0.94105269 |
| 83 | MP0002089_abnormal_postnatal_growth/wei | 0.93370549 |
| 84 | * MP0002925_abnormal_cardiovascular_devel | 0.93088152 |
| 85 | MP0005451_abnormal_body_composition | 0.92943413 |
| 86 | MP0000609_abnormal_liver_physiology | 0.92408262 |
| 87 | MP0001243_abnormal_dermal_layer | 0.91788144 |
| 88 | MP0003252_abnormal_bile_duct | 0.91758208 |
| 89 | MP0004484_altered_response_of | 0.91685641 |
| 90 | MP0003959_abnormal_lean_body | 0.89882951 |
| 91 | MP0005083_abnormal_biliary_tract | 0.89245746 |
| 92 | MP0008004_abnormal_stomach_pH | 0.89045327 |
| 93 | MP0000534_abnormal_ureter_morphology | 0.88710063 |
| 94 | MP0003115_abnormal_respiratory_system | 0.88626092 |
| 95 | MP0005164_abnormal_response_to | 0.88549976 |
| 96 | MP0005085_abnormal_gallbladder_physiolo | 0.88447405 |
| 97 | MP0001915_intracranial_hemorrhage | 0.88128629 |
| 98 | MP0003942_abnormal_urinary_system | 0.87458790 |
| 99 | MP0005595_abnormal_vascular_smooth | 0.87406838 |
| 100 | MP0000759_abnormal_skeletal_muscle | 0.85521965 |
| 101 | MP0001756_abnormal_urination | 0.85334844 |
| 102 | MP0005390_skeleton_phenotype | 0.84697244 |
| 103 | MP0009115_abnormal_fat_cell | 0.84211384 |
| 104 | MP0004883_abnormal_blood_vessel | 0.84082799 |
| 105 | MP0001661_extended_life_span | 0.84055349 |
| 106 | * MP0000266_abnormal_heart_morphology | 0.83221242 |
| 107 | * MP0005369_muscle_phenotype | 0.82542377 |
| 108 | MP0005379_endocrine/exocrine_gland_phen | 0.80890940 |
| 109 | MP0002933_joint_inflammation | 0.80476566 |
| 110 | MP0003122_maternal_imprinting | 0.80391923 |
| 111 | MP0009278_abnormal_bone_marrow | 0.80227765 |
| 112 | MP0005171_absent_coat_pigmentation | 0.79994506 |
| 113 | MP0005388_respiratory_system_phenotype | 0.77640203 |
| 114 | MP0002133_abnormal_respiratory_system | 0.77640203 |
| 115 | MP0003690_abnormal_glial_cell | 0.77366639 |
| 116 | MP0005409_darkened_coat_color | 0.76486403 |
| 117 | MP0004808_abnormal_hematopoietic_stem | 0.76301060 |
| 118 | MP0002009_preneoplasia | 0.75914896 |
| 119 | MP0001542_abnormal_bone_strength | 0.74307905 |
| 120 | MP0005334_abnormal_fat_pad | 0.73839471 |
| 121 | MP0000249_abnormal_blood_vessel | 0.73513681 |
| 122 | MP0000163_abnormal_cartilage_morphology | 0.72992901 |
| 123 | MP0001175_abnormal_lung_morphology | 0.72303252 |
| 124 | MP0005167_abnormal_blood-brain_barrier | 0.71960005 |
| 125 | MP0001851_eye_inflammation | 0.71368667 |
| 126 | * MP0002115_abnormal_skeleton_extremities | 0.69421796 |
| 127 | * MP0002106_abnormal_muscle_physiology | 0.68853167 |
| 128 | MP0005257_abnormal_intraocular_pressure | 0.68572152 |
| 129 | MP0003011_delayed_dark_adaptation | 0.68256581 |
| 130 | MP0002254_reproductive_system_inflammat | 0.67336018 |
| 131 | MP0003941_abnormal_skin_development | 0.66640796 |
| 132 | MP0000566_synostosis | 0.66530236 |
| 133 | MP0005332_abnormal_amino_acid | 0.65601753 |
| 134 | MP0003123_paternal_imprinting | 0.65519491 |
| 135 | * MP0003567_abnormal_fetal_cardiomyocyte | 0.65431919 |
| 136 | MP0002970_abnormal_white_adipose | 0.64071047 |
| 137 | MP0005448_abnormal_energy_balance | 0.63912351 |
| 138 | MP0002269_muscular_atrophy | 0.63761088 |
| 139 | MP0002998_abnormal_bone_remodeling | 0.63274023 |
| 140 | MP0002932_abnormal_joint_morphology | 0.62465669 |
| 141 | MP0005165_increased_susceptibility_to | 0.62284764 |
| 142 | MP0001348_abnormal_lacrimal_gland | 0.60849931 |
| 143 | MP0000230_abnormal_systemic_arterial | 0.59673459 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protrusio acetabuli (HP:0003179) | 6.78086213 |
| 2 | Premature rupture of membranes (HP:0001788) | 6.00789159 |
| 3 | Deep venous thrombosis (HP:0002625) | 5.69512055 |
| 4 | Ankle contracture (HP:0006466) | 5.34899829 |
| 5 | Broad metatarsal (HP:0001783) | 5.32350018 |
| 6 | Aortic dissection (HP:0002647) | 5.13633056 |
| 7 | Aortic aneurysm (HP:0004942) | 4.72052350 |
| 8 | Complement deficiency (HP:0004431) | 4.69690927 |
| 9 | Cerebral aneurysm (HP:0004944) | 4.49523737 |
| 10 | Increased connective tissue (HP:0009025) | 4.34745715 |
| 11 | Type 1 muscle fiber predominance (HP:0003803) | 4.23046099 |
| 12 | Glomerulonephritis (HP:0000099) | 4.15775379 |
| 13 | Follicular hyperkeratosis (HP:0007502) | 4.06098055 |
| 14 | Soft skin (HP:0000977) | 3.99265726 |
| 15 | Atrophic scars (HP:0001075) | 3.91915033 |
| 16 | Prolonged partial thromboplastin time (HP:0003645) | 3.81038116 |
| 17 | Shallow orbits (HP:0000586) | 3.78834976 |
| 18 | Abnormality of the common coagulation pathway (HP:0010990) | 3.76119616 |
| 19 | Spinal rigidity (HP:0003306) | 3.72869405 |
| 20 | Abnormality of complement system (HP:0005339) | 3.65002552 |
| 21 | Fragile skin (HP:0001030) | 3.57906979 |
| 22 | Abnormality of carpal bone ossification (HP:0006257) | 3.39808939 |
| 23 | Small epiphyses (HP:0010585) | 3.37330646 |
| 24 | Joint hemorrhage (HP:0005261) | 3.27881040 |
| 25 | Bladder diverticulum (HP:0000015) | 3.25862523 |
| 26 | Mitral stenosis (HP:0001718) | 3.25607513 |
| 27 | Cervical subluxation (HP:0003308) | 3.24771409 |
| 28 | Mitral valve prolapse (HP:0001634) | 3.22768452 |
| 29 | Dilatation of the ascending aorta (HP:0005111) | 3.21799182 |
| 30 | Xanthomatosis (HP:0000991) | 3.09049529 |
| 31 | Wrist flexion contracture (HP:0001239) | 3.04775907 |
| 32 | Slender build (HP:0001533) | 2.94420126 |
| 33 | Aneurysm (HP:0002617) | 2.86831306 |
| 34 | Increased variability in muscle fiber diameter (HP:0003557) | 2.84655103 |
| 35 | Blue sclerae (HP:0000592) | 2.77947277 |
| 36 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.76558588 |
| 37 | Abnormal hand bone ossification (HP:0010660) | 2.75006777 |
| 38 | Nephritis (HP:0000123) | 2.73537456 |
| 39 | Peritonitis (HP:0002586) | 2.72481979 |
| 40 | Skin nodule (HP:0200036) | 2.71908873 |
| 41 | Abnormal ossification of hand bones (HP:0005921) | 2.71693167 |
| 42 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.71145026 |
| 43 | Abnormal tarsal ossification (HP:0008369) | 2.70521891 |
| 44 | Vascular tortuosity (HP:0004948) | 2.69424847 |
| 45 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.69096993 |
| 46 | Osteolytic defects of the hand bones (HP:0009699) | 2.69096993 |
| 47 | Nonimmune hydrops fetalis (HP:0001790) | 2.68406518 |
| 48 | Lipoatrophy (HP:0100578) | 2.67461273 |
| 49 | Hypobetalipoproteinemia (HP:0003563) | 2.64617998 |
| 50 | Cardiovascular calcification (HP:0011915) | 2.64547917 |
| 51 | Epidermoid cyst (HP:0200040) | 2.63414181 |
| 52 | Wormian bones (HP:0002645) | 2.61414188 |
| 53 | Hemorrhage of the eye (HP:0011885) | 2.57200807 |
| 54 | Right ventricular cardiomyopathy (HP:0011663) | 2.55554921 |
| 55 | Arterial tortuosity (HP:0005116) | 2.55193568 |
| 56 | Hypercholesterolemia (HP:0003124) | 2.54585028 |
| 57 | Overgrowth (HP:0001548) | 2.54124879 |
| 58 | Broad palm (HP:0001169) | 2.53901552 |
| 59 | Flared iliac wings (HP:0002869) | 2.49914070 |
| 60 | Muscle fiber splitting (HP:0003555) | 2.46319569 |
| 61 | Cupped ribs (HP:0000887) | 2.44830732 |
| 62 | Syringomyelia (HP:0003396) | 2.40099750 |
| 63 | Spinal cord lesions (HP:0100561) | 2.40099750 |
| 64 | Lymphangioma (HP:0100764) | 2.39678275 |
| 65 | Systemic lupus erythematosus (HP:0002725) | 2.38572338 |
| 66 | Alacrima (HP:0000522) | 2.34069539 |
| 67 | Ovoid vertebral bodies (HP:0003300) | 2.33045248 |
| 68 | Flat acetabular roof (HP:0003180) | 2.31961319 |
| 69 | Vascular calcification (HP:0004934) | 2.30817233 |
| 70 | Joint laxity (HP:0001388) | 2.30735053 |
| 71 | Hypolipoproteinemia (HP:0010981) | 2.28938687 |
| 72 | Asymmetry of the thorax (HP:0001555) | 2.28871176 |
| 73 | Abnormality of dentin (HP:0010299) | 2.26682994 |
| 74 | Spondylolisthesis (HP:0003302) | 2.26664657 |
| 75 | Hyporeflexia of lower limbs (HP:0002600) | 2.26021263 |
| 76 | Acanthosis nigricans (HP:0000956) | 2.23485848 |
| 77 | Epiphyseal dysplasia (HP:0002656) | 2.23375401 |
| 78 | Hematochezia (HP:0002573) | 2.22775295 |
| 79 | Striae distensae (HP:0001065) | 2.22414178 |
| 80 | Alopecia of scalp (HP:0002293) | 2.21708862 |
| 81 | Menorrhagia (HP:0000132) | 2.21556560 |
| 82 | Vertebral compression fractures (HP:0002953) | 2.20915642 |
| 83 | Hyperextensible skin (HP:0000974) | 2.20843435 |
| 84 | Venous abnormality (HP:0002624) | 2.20714977 |
| 85 | Camptodactyly of toe (HP:0001836) | 2.20588071 |
| 86 | Limited elbow extension (HP:0001377) | 2.20472705 |
| 87 | Myocardial infarction (HP:0001658) | 2.20338273 |
| 88 | Abnormality of the wing of the ilium (HP:0011867) | 2.19679032 |
| 89 | Abnormality of the nasal septum (HP:0000419) | 2.19504255 |
| 90 | Abnormal foot bone ossification (HP:0010675) | 2.16672218 |
| 91 | Aplasia involving bones of the extremities (HP:0009825) | 2.15698360 |
| 92 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.15698360 |
| 93 | Aplasia of the phalanges of the hand (HP:0009802) | 2.15698360 |
| 94 | Short hallux (HP:0010109) | 2.15349048 |
| 95 | Wide anterior fontanel (HP:0000260) | 2.15332432 |
| 96 | Abnormal delivery (HP:0001787) | 2.13987593 |
| 97 | Pigmentary retinal degeneration (HP:0001146) | 2.13514901 |
| 98 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.12881430 |
| 99 | Short 4th metacarpal (HP:0010044) | 2.12881430 |
| 100 | Abnormality of the radial head (HP:0003995) | 2.12344012 |
| 101 | Coxa vara (HP:0002812) | 2.11639102 |
| 102 | Generalized amyotrophy (HP:0003700) | 2.11624627 |
| 103 | Neonatal short-limb short stature (HP:0008921) | 2.11318245 |
| 104 | Biconcave vertebral bodies (HP:0004586) | 2.09949610 |
| 105 | Venous insufficiency (HP:0005293) | 2.09306199 |
| 106 | Mesangial abnormality (HP:0001966) | 2.06708896 |
| 107 | Genu recurvatum (HP:0002816) | 2.06568276 |
| 108 | Ventricular tachycardia (HP:0004756) | 2.05830071 |
| 109 | Hypoalphalipoproteinemia (HP:0003233) | 2.04655360 |
| 110 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.03925174 |
| 111 | Osteoarthritis (HP:0002758) | 2.03755686 |
| 112 | Dislocated radial head (HP:0003083) | 2.03496039 |
| 113 | Hypoplasia of the iris (HP:0007676) | 1.99359811 |
| 114 | Pulmonary artery stenosis (HP:0004415) | 1.99197882 |
| 115 | Decreased lacrimation (HP:0000633) | 1.99092069 |
| 116 | Thin bony cortex (HP:0002753) | 1.98363039 |
| 117 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.98282773 |
| 118 | Bowel diverticulosis (HP:0005222) | 1.97739642 |
| 119 | Mesomelia (HP:0003027) | 1.96252088 |
| 120 | Rectal prolapse (HP:0002035) | 1.95819882 |
| 121 | Round ear (HP:0100830) | 1.95507917 |
| 122 | Elbow flexion contracture (HP:0002987) | 1.95177281 |
| 123 | Spontaneous abortion (HP:0005268) | 1.93930470 |
| 124 | Facial shape deformation (HP:0011334) | 1.93568230 |
| 125 | Potter facies (HP:0002009) | 1.93568230 |
| 126 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.93463844 |
| 127 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.92554256 |
| 128 | Acanthocytosis (HP:0001927) | 1.92066213 |
| 129 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.91294175 |
| 130 | Hypoglycemic coma (HP:0001325) | 1.91056044 |
| 131 | Abnormality of the 4th metacarpal (HP:0010012) | 1.90084877 |
| 132 | Ectopia lentis (HP:0001083) | 1.89577268 |
| 133 | Enlarged penis (HP:0000040) | 1.89472694 |
| 134 | Arthropathy (HP:0003040) | 1.88296098 |
| 135 | Aortic regurgitation (HP:0001659) | 1.85907314 |
| 136 | Gingival bleeding (HP:0000225) | 1.85327654 |
| 137 | Esophageal varix (HP:0002040) | 1.84592545 |
| 138 | Atrial fibrillation (HP:0005110) | 1.84179221 |
| 139 | Subacute progressive viral hepatitis (HP:0006572) | 1.84133552 |
| 140 | Exercise-induced muscle cramps (HP:0003710) | 1.83035469 |
| 141 | Abnormality of the lacrimal duct (HP:0011481) | 1.81477661 |
| 142 | Abnormality of the acetabulum (HP:0003170) | 1.78300538 |
| 143 | Abnormality of the calf musculature (HP:0001430) | 1.77339675 |
| 144 | Persistence of primary teeth (HP:0006335) | 1.77097615 |
| 145 | Recurrent corneal erosions (HP:0000495) | 1.76638233 |
| 146 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.76602276 |
| 147 | Abnormality of the nasolacrimal system (HP:0000614) | 1.76433417 |
| 148 | Limb-girdle muscle weakness (HP:0003325) | 1.76191832 |
| 149 | Broad alveolar ridges (HP:0000187) | 1.75261792 |
| 150 | Abnormality of the intrinsic pathway (HP:0010989) | 1.74514412 |
| 151 | Hypoglycemic seizures (HP:0002173) | 1.74352852 |
| 152 | Testicular neoplasm (HP:0010788) | 1.73789335 |
| 153 | Scapular winging (HP:0003691) | 1.73677762 |
| 154 | Flexion contracture of toe (HP:0005830) | 1.73623887 |
| 155 | Joint contractures involving the joints of the feet (HP:0100492) | 1.73623887 |
| 156 | Gingival overgrowth (HP:0000212) | 1.73477934 |
| 157 | Tarsal synostosis (HP:0008368) | 1.72387521 |
| 158 | Wide nose (HP:0000445) | 1.71020158 |
| 159 | Mitral regurgitation (HP:0001653) | 1.70891619 |
| 160 | Chondrocalcinosis (HP:0000934) | 1.70807395 |
| 161 | Ulnar bowing (HP:0003031) | 1.69929526 |
| 162 | Impaired pain sensation (HP:0007328) | 1.69735143 |
| 163 | Abnormality of pain sensation (HP:0010832) | 1.69735143 |
| 164 | Inguinal hernia (HP:0000023) | 1.69233663 |
| 165 | Knee flexion contracture (HP:0006380) | 1.68426390 |
| 166 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.67123792 |
| 167 | Supraventricular arrhythmia (HP:0005115) | 1.65787446 |
| 168 | Nasolacrimal duct obstruction (HP:0000579) | 1.65616511 |
| 169 | Dilated cardiomyopathy (HP:0001644) | 1.64642835 |
| 170 | Bone cyst (HP:0012062) | 1.64638069 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 6.01889805 |
| 2 | TTN | 3.08190752 |
| 3 | TGFBR2 | 3.07952229 |
| 4 | TRIB3 | 3.01568048 |
| 5 | KDR | 2.95732301 |
| 6 | LATS1 | 2.86304280 |
| 7 | PDGFRA | 2.66708180 |
| 8 | ICK | 2.52907773 |
| 9 | MYLK | 2.39131971 |
| 10 | SIK1 | 2.32198332 |
| 11 | WNK4 | 2.31819538 |
| 12 | PKN2 | 2.02233092 |
| 13 | ERN1 | 2.01392898 |
| 14 | DDR2 | 1.99755484 |
| 15 | CAMK1D | 1.97652233 |
| 16 | TGFBR1 | 1.89474635 |
| 17 | RIPK1 | 1.89151491 |
| 18 | TYRO3 | 1.85594400 |
| 19 | OBSCN | 1.78326302 |
| 20 | EPHB2 | 1.73406287 |
| 21 | TRPM7 | 1.71641137 |
| 22 | DMPK | 1.67559004 |
| 23 | EPHA3 | 1.67225984 |
| 24 | STK3 | 1.65272913 |
| 25 | FGFR4 | 1.54000430 |
| 26 | CDK12 | 1.53829085 |
| 27 | PIK3CA | 1.45733802 |
| 28 | EPHB1 | 1.43007149 |
| 29 | FER | 1.41613070 |
| 30 | JAK3 | 1.40112587 |
| 31 | FRK | 1.39386757 |
| 32 | NEK9 | 1.39323372 |
| 33 | FGFR3 | 1.35268990 |
| 34 | LATS2 | 1.34714808 |
| 35 | CAMK1G | 1.33791686 |
| 36 | STK39 | 1.32423769 |
| 37 | PTK2B | 1.29382827 |
| 38 | NUAK1 | 1.28877740 |
| 39 | MAP3K2 | 1.24951840 |
| 40 | PTK6 | 1.24908256 |
| 41 | BCKDK | 1.24163859 |
| 42 | MAP3K6 | 1.20196160 |
| 43 | STK38 | 1.19620772 |
| 44 | PDK2 | 1.16548892 |
| 45 | PDGFRB | 1.05282743 |
| 46 | MELK | 1.04153749 |
| 47 | PAK2 | 1.04136050 |
| 48 | STK24 | 1.02307749 |
| 49 | MAP2K3 | 1.02214268 |
| 50 | FGFR2 | 0.95777585 |
| 51 | BMX | 0.94738325 |
| 52 | SGK2 | 0.93799986 |
| 53 | JAK1 | 0.93285507 |
| 54 | EEF2K | 0.91430103 |
| 55 | INSRR | 0.91207468 |
| 56 | MAP3K3 | 0.90820916 |
| 57 | PDK4 | 0.86604757 |
| 58 | PDK3 | 0.86604757 |
| 59 | FGFR1 | 0.86593759 |
| 60 | NLK | 0.86088534 |
| 61 | STK38L | 0.84260096 |
| 62 | PDPK1 | 0.83401611 |
| 63 | LMTK2 | 0.83243812 |
| 64 | PAK4 | 0.82092794 |
| 65 | SGK223 | 0.80215239 |
| 66 | SGK494 | 0.80215239 |
| 67 | PTK2 | 0.79762864 |
| 68 | LRRK2 | 0.79513534 |
| 69 | PDK1 | 0.78631205 |
| 70 | MAPK11 | 0.75592782 |
| 71 | MTOR | 0.75570970 |
| 72 | PRKCH | 0.75238463 |
| 73 | TEC | 0.75216649 |
| 74 | CSK | 0.74580833 |
| 75 | MAP3K13 | 0.73887112 |
| 76 | ILK | 0.70975175 |
| 77 | TXK | 0.70950230 |
| 78 | ZAP70 | 0.67687219 |
| 79 | PRKD3 | 0.67187330 |
| 80 | FLT3 | 0.66950253 |
| 81 | ROCK1 | 0.66444070 |
| 82 | MARK2 | 0.65792291 |
| 83 | AKT3 | 0.65163638 |
| 84 | BRD4 | 0.64499587 |
| 85 | MAP3K1 | 0.63615511 |
| 86 | ZAK | 0.63131402 |
| 87 | PRKAA2 | 0.62401125 |
| 88 | PRKAA1 | 0.61541043 |
| 89 | PRKD2 | 0.58197999 |
| 90 | MAPKAPK3 | 0.57740031 |
| 91 | KIT | 0.57591691 |
| 92 | RET | 0.57394452 |
| 93 | ITK | 0.56826638 |
| 94 | KSR2 | 0.55791245 |
| 95 | PRKD1 | 0.55694783 |
| 96 | TAOK3 | 0.54231774 |
| 97 | MST1R | 0.52477017 |
| 98 | SGK1 | 0.52434849 |
| 99 | MET | 0.52427384 |
| 100 | CDK6 | 0.51128888 |
| 101 | GRK5 | 0.50037777 |
| 102 | MAP3K7 | 0.49091739 |
| 103 | STK10 | 0.48960347 |
| 104 | MAP2K1 | 0.47484819 |
| 105 | MAPK12 | 0.45800461 |
| 106 | CDC42BPA | 0.44823952 |
| 107 | RPS6KA4 | 0.44390321 |
| 108 | CAMKK2 | 0.44185160 |
| 109 | IGF1R | 0.43764807 |
| 110 | ERBB2 | 0.40669101 |
| 111 | CAMK4 | 0.40571921 |
| 112 | PRKG2 | 0.40161021 |
| 113 | MAPK3 | 0.39599957 |
| 114 | GSK3A | 0.39368978 |
| 115 | MAP2K6 | 0.38979698 |
| 116 | INSR | 0.38787618 |
| 117 | SGK3 | 0.37857523 |
| 118 | CDK9 | 0.37059673 |
| 119 | RPS6KB1 | 0.35266781 |
| 120 | LCK | 0.33914298 |
| 121 | SRC | 0.32670279 |
| 122 | RPS6KC1 | 0.32656943 |
| 123 | RPS6KL1 | 0.32656943 |
| 124 | RPS6KA6 | 0.32436458 |
| 125 | JAK2 | 0.32267119 |
| 126 | PAK3 | 0.32217785 |
| 127 | NTRK1 | 0.31435043 |
| 128 | CDK8 | 0.31326380 |
| 129 | MAPK7 | 0.28230617 |
| 130 | ADRBK1 | 0.27187564 |
| 131 | PIK3CG | 0.26995477 |
| 132 | CHUK | 0.26939727 |
| 133 | YES1 | 0.26541516 |
| 134 | MAPK1 | 0.26405183 |
| 135 | MAPKAPK2 | 0.25052369 |
| 136 | WNK1 | 0.24976322 |
| 137 | TYK2 | 0.24442016 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ECM-receptor interaction_Homo sapiens_hsa04512 | 4.29321085 |
| 2 | Focal adhesion_Homo sapiens_hsa04510 | 3.05249212 |
| 3 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.50239677 |
| 4 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.41225037 |
| 5 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.27800996 |
| 6 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 2.23476011 |
| 7 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 2.15668184 |
| 8 | Small cell lung cancer_Homo sapiens_hsa05222 | 2.14325890 |
| 9 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.08181037 |
| 10 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.06153034 |
| 11 | Adherens junction_Homo sapiens_hsa04520 | 2.04774502 |
| 12 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.02913078 |
| 13 | Amoebiasis_Homo sapiens_hsa05146 | 1.98700554 |
| 14 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.96784302 |
| 15 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.90950010 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.88622606 |
| 17 | Malaria_Homo sapiens_hsa05144 | 1.81844185 |
| 18 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.77955541 |
| 19 | ABC transporters_Homo sapiens_hsa02010 | 1.76922784 |
| 20 | Viral myocarditis_Homo sapiens_hsa05416 | 1.66030678 |
| 21 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.64813347 |
| 22 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.64510470 |
| 23 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.64217814 |
| 24 | Circadian rhythm_Homo sapiens_hsa04710 | 1.61198074 |
| 25 | Histidine metabolism_Homo sapiens_hsa00340 | 1.58992987 |
| 26 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.55355375 |
| 27 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.51187897 |
| 28 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.41763871 |
| 29 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.41591528 |
| 30 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.39571589 |
| 31 | Platelet activation_Homo sapiens_hsa04611 | 1.35522684 |
| 32 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.34311918 |
| 33 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.33613363 |
| 34 | Insulin resistance_Homo sapiens_hsa04931 | 1.33163151 |
| 35 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.30851452 |
| 36 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.28827808 |
| 37 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.26868349 |
| 38 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.23891108 |
| 39 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.22322834 |
| 40 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.21771233 |
| 41 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.21343357 |
| 42 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.19841111 |
| 43 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.19057652 |
| 44 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.18614807 |
| 45 | Pathways in cancer_Homo sapiens_hsa05200 | 1.18119663 |
| 46 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.16060203 |
| 47 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.15940798 |
| 48 | Bile secretion_Homo sapiens_hsa04976 | 1.15850053 |
| 49 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.15644178 |
| 50 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.14844012 |
| 51 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.11169439 |
| 52 | Other glycan degradation_Homo sapiens_hsa00511 | 1.10537491 |
| 53 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 1.10229476 |
| 54 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.08168150 |
| 55 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.07265927 |
| 56 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.06588561 |
| 57 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.06419629 |
| 58 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.05244619 |
| 59 | Melanoma_Homo sapiens_hsa05218 | 1.02302625 |
| 60 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.00153322 |
| 61 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.99038972 |
| 62 | Prostate cancer_Homo sapiens_hsa05215 | 0.95736171 |
| 63 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.94716266 |
| 64 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.94174234 |
| 65 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.93837410 |
| 66 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.92748877 |
| 67 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.89104655 |
| 68 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.85675702 |
| 69 | HTLV-I infection_Homo sapiens_hsa05166 | 0.85480708 |
| 70 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.85432931 |
| 71 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.83975197 |
| 72 | Lysine degradation_Homo sapiens_hsa00310 | 0.83109553 |
| 73 | Prion diseases_Homo sapiens_hsa05020 | 0.82984120 |
| 74 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.81948974 |
| 75 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.81452241 |
| 76 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.81236339 |
| 77 | Tight junction_Homo sapiens_hsa04530 | 0.80484362 |
| 78 | Thyroid cancer_Homo sapiens_hsa05216 | 0.79772832 |
| 79 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.77141841 |
| 80 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.75662906 |
| 81 | Bladder cancer_Homo sapiens_hsa05219 | 0.74615373 |
| 82 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.74144491 |
| 83 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.70747130 |
| 84 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.70718707 |
| 85 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.69480724 |
| 86 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.69143984 |
| 87 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.68438488 |
| 88 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.66723751 |
| 89 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.66352740 |
| 90 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.66242762 |
| 91 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.65714154 |
| 92 | Pertussis_Homo sapiens_hsa05133 | 0.65385913 |
| 93 | Endometrial cancer_Homo sapiens_hsa05213 | 0.64201914 |
| 94 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.63709412 |
| 95 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.62292499 |
| 96 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.61243411 |
| 97 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.60708965 |
| 98 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.60627920 |
| 99 | Mineral absorption_Homo sapiens_hsa04978 | 0.60057435 |
| 100 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.59383523 |
| 101 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.57867820 |
| 102 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.56235375 |
| 103 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.55138373 |
| 104 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.53538693 |
| 105 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.53332697 |
| 106 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.52942469 |
| 107 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.52059904 |
| 108 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.51427929 |
| 109 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.51173408 |
| 110 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.49997378 |
| 111 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.49412391 |
| 112 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.49243115 |
| 113 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.48633834 |
| 114 | Carbon metabolism_Homo sapiens_hsa01200 | 0.47694086 |
| 115 | Glioma_Homo sapiens_hsa05214 | 0.45669866 |
| 116 | Hepatitis B_Homo sapiens_hsa05161 | 0.45564311 |
| 117 | Melanogenesis_Homo sapiens_hsa04916 | 0.45419791 |
| 118 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.44942810 |
| 119 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.44174797 |
| 120 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.43644558 |
| 121 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.42861242 |
| 122 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.42031058 |
| 123 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.40785122 |
| 124 | Colorectal cancer_Homo sapiens_hsa05210 | 0.40691617 |
| 125 | Galactose metabolism_Homo sapiens_hsa00052 | 0.40130920 |
| 126 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.40049342 |
| 127 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.39790717 |
| 128 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.39101746 |
| 129 | Retinol metabolism_Homo sapiens_hsa00830 | 0.39049083 |
| 130 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.38188416 |
| 131 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.38122733 |
| 132 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.38094078 |
| 133 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.37967915 |
| 134 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.37803598 |
| 135 | Renin secretion_Homo sapiens_hsa04924 | 0.37389545 |
| 136 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.37382591 |
| 137 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.37222283 |
| 138 | Apoptosis_Homo sapiens_hsa04210 | 0.36251522 |
| 139 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.36246553 |

